RUNX3 and neoplasm: Considering the results in the current study and previous findings together, we speculated that attenuation of exp‐CAF 544 cells' tumor‐promoting ability by RUNX3 knockdown is likely dependent on a signaling pathway(s) in which neither SDF‐1 nor TGF‐β is involved.